| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
144,920,000 |
| Market
Cap: |
30.57(B) |
| Last
Volume: |
411,980 |
Avg
Vol: |
722,028 |
| 52
Week Range: |
$134.65 - $225.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 516 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
28,828 |
40,044 |
80,722 |
293,941 |
| Total Sell Value |
$6,175,134 |
$8,221,798 |
$15,438,107 |
$63,204,606 |
| Total People Sold |
4 |
6 |
8 |
11 |
| Total Sell Transactions |
5 |
8 |
23 |
74 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hollingshead James |
President, Sleep Business |
• • – |
2020-01-02 |
4 |
AS |
$155.40 |
$186,480 |
D/D |
(1,200) |
93,174 |
|
10% |
|
| Douglas Robert Andrew |
President and COO ResMed Inc. |
• • – |
2019-12-16 |
4 |
AS |
$154.71 |
$201,432 |
I/I |
(1,302) |
152,044 |
|
- |
|
| Sandercock Brett |
Chief Financial Officer |
• • – |
2019-12-16 |
4 |
AS |
$154.71 |
$386,775 |
D/D |
(2,500) |
102,211 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2019-12-09 |
4 |
AS |
$149.64 |
$995,282 |
D/D |
(6,651) |
354,700 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2019-12-09 |
4 |
OE |
$43.63 |
$290,183 |
D/D |
6,651 |
361,351 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2019-12-03 |
4 |
AS |
$148.94 |
$705,827 |
D/D |
(4,739) |
130,564 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2019-12-03 |
4 |
OE |
$58.24 |
$275,999 |
D/D |
4,739 |
134,943 |
|
- |
|
| Hollingshead James |
President, Sleep Business |
• • – |
2019-12-02 |
4 |
AS |
$149.89 |
$239,824 |
D/D |
(1,600) |
94,374 |
|
- |
|
| Hollingshead James |
President, Sleep Business |
• • – |
2019-12-02 |
4 |
OE |
$58.24 |
$46,592 |
D/D |
800 |
95,974 |
|
- |
|
| Sodhi Rajwant |
President, SaaS Business |
• • – |
2019-12-02 |
4 |
AS |
$149.89 |
$202,352 |
D/D |
(1,350) |
39,870 |
|
- |
|
| Gill Harjit |
Director |
• • – |
2019-11-27 |
4 |
D |
$143.88 |
$14,676 |
D/D |
(102) |
4,158 |
|
- |
|
| Sandercock Brett |
Chief Financial Officer |
• • – |
2019-11-26 |
4 |
AS |
$147.00 |
$367,500 |
D/D |
(2,500) |
104,711 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2019-11-26 |
4 |
S |
$149.26 |
$204,489 |
I/I |
(1,370) |
0 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2019-11-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,370 |
1,370 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2019-11-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,370 |
8,970 |
|
- |
|
| Mchale Richard |
President, RC Business |
• • – |
2019-11-25 |
4 |
S |
$146.10 |
$438,285 |
D/D |
(3,000) |
20,670 |
|
- |
|
| Taylor Ronald R |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
21,582 |
|
- |
|
| Drexler Karen |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
863 |
6,387 |
|
- |
|
| Sulpizio Richard |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
11,680 |
|
- |
|
| Gill Harjit |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
4,260 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
228,028 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
3,133 |
|
- |
|
| Burt Carol |
Director |
• • – |
2019-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,727 |
25,205 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2019-11-21 |
4 |
D |
$146.34 |
$2,567,974 |
D/D |
(17,548) |
130,564 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2019-11-21 |
4 |
A |
$146.34 |
$4,603,564 |
D/D |
31,458 |
148,112 |
|
- |
|
2147 Records found
|
|
Page 19 of 86 |
|
|
0.65 (0.31%) 
